← Leaderboards
Lei Zhu
Migra-Therapeutics, Llc
$954,772
Attributed
$2,331,145
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $934.4K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,331,145 · 3
By mechanism
R44$1,776,357 · 1
R41$330,363 · 1
R43$224,425 · 1
Top collaborators
- Lily Yang5 shared
- H Trent Spencer2 shared
- Lingxun Duan1 shared
Others in their field
Other Emerging Leaders on “Targeted Delivery”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$58,495,626
- Alan D. Palkowitz · Indiana University Indianapolis$20,749,664
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,710,336
- Timothy M Willson · University Of Cape Town$12,760,250
Research focus
Targeted DeliveryTherapeutic AgentsResearch Project GrantsMmp14 GenePancreatic Cancer PatientsPancreatic Cancer CellsIn VitroRecombinantsIrinotecanMalignant Neoplasm Of PancreasNovel StrategiesNeoplastic CellEngineeringDuct (Organ) StructureFutureDrug Delivery SystemsNanoparticle DrugCatalytic DomainClinical TrialsDesignLeadLigandsCancer PatientTherapeutic Effect
Grant awards (5)
Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy$841,919
R44 · FY2023 · CA · contact PI
Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy$934,438
R44 · FY2022 · CA · contact PI
Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents$224,860
R41 · FY2020 · CA
Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents$105,503
R41 · FY2020 · CA
Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy$224,425
R43 · FY2019 · CA · contact PI